Ex vivo lung perfusion in lung transplantation

Author:

Fabrika A. P.1ORCID,Tychina E. P.1ORCID,Bayramkulov A. M.1ORCID,Tarabrin E. A.2ORCID

Affiliation:

1. I.M. Sechenov First Moscow State Medical University (Sechenov University)

2. I.M. Sechenov First Moscow State Medical University (Sechenov University); N.V. Sklifosovsky Research Institute for Emergency Medicine

Abstract

Introduction. The number of lung transplants performed worldwide is not enough because of a shortage of suitable (ideal) donors, missed chances to use lungs from donors who died of cardiac arrest, the lack of resources to perform this technically complex operation in poor, developing countries and due to a number of other reasons.) The world literature sources contain information about an increase in the number of lung transplantations by using organs from non-ideal (suboptimal and marginal) donors. This became possible thanks to the technology of ex vivo normothermic perfusion of donor lungs.Aim. To demonstrate the possibilities in the assessment, therapy and restoration of the function of non-ideal (suboptimal and marginal) donor lungs by using the technique of ex vivo lung perfusion.Material and methods. We reviewed scientific articles published in the period from 2003 to 2023 in the PubMed and Google Scholar databases for the key query "ex vivo lung perfusion".Conclusion. The ex vivo lung perfusion technique is a promising and effective procedure for lung evaluation, recondition and regeneration for) transplantation. A rapid development of technologies for this treatment modality makes it possible to increase the number of lungs suitable for transplantation, reduce the number of post-transplant complications and mortality rates on the waiting list, and improve the outcomes of lung transplantations.

Publisher

IPO Association of Transplantologists

Reference58 articles.

1. Brandsma CA, Van den Berge M, Hackett TL, Brusselle G, Timens W. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine. J Pathol. 2020;250(5):624– 635. PMID: 31691283 https://doi.org/10.1002/path.5364

2. Watanabe T, Cypel M, Keshavjee S. Ex vivo lung perfusion. J Thorac Dis. 2021;13(11):6602–6617. PMID: 34992839 https://doi.org/10.21037/jtd-2021-23

3. Reeb J, Cypel M. Ex vivo lung perfusion. Clin Transplant. 2016;30(3):183–194. PMID: 26700566 https://doi.org/10.1111/ctr.12680

4. Tarabrin EA. Transplantatsiya legkikh: organizatsionnye i tekhnicheskie printsipy: Dr. med. sci. diss. Moscow; 2019. Available at: https://sklif.mos.ru/upload/iblock/28d/28d5d86ee58d33de5c1841a8f1c922fc.pdf [Accessed September 15, 2023]. (In Russ.).

5. Kallagov TE. Ispol'zovanie suboptimal'nykh donorov dlya transplantatsii legkikh: Cand. med. sci. diss. Moscow; 2022. Available at: https://sklif.mos.ru/upload/iblock/9e4/lk9etwd2988f9208f1ggol4q7xpwkdyu.pdf [Accessed September 15, 2023]. (In Russ.).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3